225 related articles for article (PubMed ID: 30638292)
1. Structure, function, and inhibition of a genomic/clinical variant of Porphyromonas gingivalis peptidylarginine deiminase.
Bereta G; Goulas T; Madej M; Bielecka E; Solà M; Potempa J; Gomis-Rüth FX
Protein Sci; 2019 Mar; 28(3):478-486. PubMed ID: 30638292
[TBL] [Abstract][Full Text] [Related]
2. Structure and mechanism of a bacterial host-protein citrullinating virulence factor, Porphyromonas gingivalis peptidylarginine deiminase.
Goulas T; Mizgalska D; Garcia-Ferrer I; Kantyka T; Guevara T; Szmigielski B; Sroka A; Millán C; Usón I; Veillard F; Potempa B; Mydel P; Solà M; Potempa J; Gomis-Rüth FX
Sci Rep; 2015 Jul; 5():11969. PubMed ID: 26132828
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of Porphyromonas gingivalis peptidylarginine deiminase: implications for autoimmunity in rheumatoid arthritis.
Montgomery AB; Kopec J; Shrestha L; Thezenas ML; Burgess-Brown NA; Fischer R; Yue WW; Venables PJ
Ann Rheum Dis; 2016 Jun; 75(6):1255-61. PubMed ID: 26209657
[TBL] [Abstract][Full Text] [Related]
4. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
Quirke AM; Lugli EB; Wegner N; Hamilton BC; Charles P; Chowdhury M; Ytterberg AJ; Zubarev RA; Potempa J; Culshaw S; Guo Y; Fisher BA; Thiele G; Mikuls TR; Venables PJ
Ann Rheum Dis; 2014 Jan; 73(1):263-9. PubMed ID: 23463691
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Proteome and Citrullinome of the Oral Pathogen Porphyromonas gingivalis.
Stobernack T; Glasner C; Junker S; Gabarrini G; de Smit M; de Jong A; Otto A; Becher D; van Winkelhoff AJ; van Dijl JM
J Proteome Res; 2016 Dec; 15(12):4532-4543. PubMed ID: 27712078
[TBL] [Abstract][Full Text] [Related]
7. There's no place like OM: Vesicular sorting and secretion of the peptidylarginine deiminase of Porphyromonas gingivalis.
Gabarrini G; Palma Medina LM; Stobernack T; Prins RC; du Teil Espina M; Kuipers J; Chlebowicz MA; Rossen JWA; van Winkelhoff AJ; van Dijl JM
Virulence; 2018 Jan; 9(1):456-464. PubMed ID: 29505395
[TBL] [Abstract][Full Text] [Related]
8. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.
Konig MF; Paracha AS; Moni M; Bingham CO; Andrade F
Ann Rheum Dis; 2015 Nov; 74(11):2054-61. PubMed ID: 24864075
[TBL] [Abstract][Full Text] [Related]
9. Dropping anchor: attachment of peptidylarginine deiminase via A-LPS to secreted outer membrane vesicles of Porphyromonas gingivalis.
Gabarrini G; Heida R; van Ieperen N; Curtis MA; van Winkelhoff AJ; van Dijl JM
Sci Rep; 2018 Jun; 8(1):8949. PubMed ID: 29895934
[TBL] [Abstract][Full Text] [Related]
10. A Secreted Bacterial Peptidylarginine Deiminase Can Neutralize Human Innate Immune Defenses.
Stobernack T; du Teil Espina M; Mulder LM; Palma Medina LM; Piebenga DR; Gabarrini G; Zhao X; Janssen KMJ; Hulzebos J; Brouwer E; Sura T; Becher D; van Winkelhoff AJ; Götz F; Otto A; Westra J; van Dijl JM
mBio; 2018 Oct; 9(5):. PubMed ID: 30377277
[TBL] [Abstract][Full Text] [Related]
11. Bacterial citrullinated epitopes generated by
Jenning M; Marklein B; Ytterberg J; Zubarev RA; Joshua V; van Schaardenburg D; van de Stadt L; Catrina AI; Nonhoff U; Häupl T; Konthur Z; Burmester GR; Skriner K
Ann Rheum Dis; 2020 Sep; 79(9):1194-1202. PubMed ID: 32532752
[TBL] [Abstract][Full Text] [Related]
12. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
[TBL] [Abstract][Full Text] [Related]
13. Conserved Citrullinating Exoenzymes in Porphyromonas Species.
Gabarrini G; Chlebowicz MA; Vega Quiroz ME; Veloo ACM; Rossen JWA; Harmsen HJM; Laine ML; van Dijl JM; van Winkelhoff AJ
J Dent Res; 2018 May; 97(5):556-562. PubMed ID: 29298553
[TBL] [Abstract][Full Text] [Related]
14. Identification of a new genetic variant (G231N, E232T, N235D) of peptidylarginine deiminase from
Bereta GP; Strzelec K; Łazarz-Bartyzel K; Dziedzic-Kowalska A; Nowakowska Z; Krutyhołowa A; Bielecka E; Kantyka T; Grabiec AM; Kaczmarzyk T; Chomyszyn-Gajewska M; Potempa J; Gawron K
Front Immunol; 2024; 15():1355357. PubMed ID: 38576615
[TBL] [Abstract][Full Text] [Related]
15. The peptidylarginine deiminase gene is a conserved feature of Porphyromonas gingivalis.
Gabarrini G; de Smit M; Westra J; Brouwer E; Vissink A; Zhou K; Rossen JW; Stobernack T; van Dijl JM; van Winkelhoff AJ
Sci Rep; 2015 Sep; 5():13936. PubMed ID: 26403779
[TBL] [Abstract][Full Text] [Related]
16. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
Vitkov L; Hannig M; Minnich B; Herrmann M
Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
[TBL] [Abstract][Full Text] [Related]
17. Peptidylarginine deiminase from Porphyromonas gingivalis contributes to infection of gingival fibroblasts and induction of prostaglandin E2 -signaling pathway.
Gawron K; Bereta G; Nowakowska Z; Lazarz-Bartyzel K; Lazarz M; Szmigielski B; Mizgalska D; Buda A; Koziel J; Oruba Z; Chomyszyn-Gajewska M; Potempa J
Mol Oral Microbiol; 2014 Dec; 29(6):321-32. PubMed ID: 25176110
[TBL] [Abstract][Full Text] [Related]
18. Peptidyl arginine deiminase from Porphyromonas gingivalis abolishes anaphylatoxin C5a activity.
Bielecka E; Scavenius C; Kantyka T; Jusko M; Mizgalska D; Szmigielski B; Potempa B; Enghild JJ; Prossnitz ER; Blom AM; Potempa J
J Biol Chem; 2014 Nov; 289(47):32481-7. PubMed ID: 25324545
[TBL] [Abstract][Full Text] [Related]
19. Porphyromonas gulae and PPAD antibodies are not related to citrullination in rheumatoid arthritis.
Castellar-Mendoza C; Castillo DM; Chila-Moreno L; Bautista-Molano W; Romero-Sánchez C
Clin Oral Investig; 2023 Jul; 27(7):3509-3519. PubMed ID: 37133700
[TBL] [Abstract][Full Text] [Related]
20. PPAD Activity Promotes Outer Membrane Vesicle Biogenesis and Surface Translocation by Porphyromonas gingivalis.
Vermilyea DM; Moradali MF; Kim HM; Davey ME
J Bacteriol; 2021 Jan; 203(4):. PubMed ID: 33257525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
